Non-motor signs in Parkinson’s disease: A review;Sinais não motores na doença de Parkinson: Uma revisão

Arquivos de Neuro-Psiquiatria

Volumn 73, Issue 5, 2015, Pages 454-462

  Munhoz, Renato P ^a   Moro, Adriana ^b,c   Silveira Moriyama, Laura ^d   Teive, Helio A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c Associacao Paranaense Dos Portadores de Parkinsonismo   (Brazil)

^d UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

Dementia; Hyposmia; Non motor signs; Parkinson s disease; Psychosis

Indexed keywords

AUTONOMIC DYSFUNCTION; COGNITIVE DEFECT; CONSTIPATION; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE COURSE; FATIGUE; FUNCTIONAL STATUS ASSESSMENT; HUMAN; METABOLIC DISORDER; NON MOTOR SIGN; PARASOMNIA; PARKINSON DISEASE; PREVALENCE; PSYCHOSIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SENSORY DYSFUNCTION; VITAL SIGN; WEIGHT REDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SMELLING DISORDER;

COGNITION DISORDERS; CONSTIPATION; HUMANS; OLFACTION DISORDERS; PARKINSON DISEASE; PSYCHOTIC DISORDERS; QUALITY OF LIFE; REM SLEEP BEHAVIOR DISORDER; RISK FACTORS; WEIGHT LOSS;

EID: 84929643139     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20150029     Document Type: Review

References (60)

1. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci. 1991;18(3):275-8.
2. Braak H, Del Tredici K, Rüb U, Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197-211.
3. Jellinger KA. A critical evaluation of current staging of alphasynuclein pathology in Lewy body disorders. Biochim Biophys Acta. 2009;1792:730-40.http://dx.doi.org/10.1016/S0197-4580(02)00065-9
4. Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson’s disease. Ann Neurol. 2008;64(5):485-91.http://dx.doi.org/10.1002/ana.21541
5. Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W et al. Brain stem pathology in Parkinson’s disease: an evaluation of the Braak staging model. Mov Disord. 2010;25(15):2508-15.http://dx.doi.org/10.1002/mds.23305
6. Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;249(11):1641-9.http://dx.doi.org/10.1002/mds.22643
7. Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Parkinson’s disease: the non-motor issues. Parkinsonism Relat Disord. 2011;17(10):717-23.http://dx.doi.org/10.1016/j.parkreldis.2011.02.018
8. Schrag A. Quality of life and depression in Parkinson’s disease. J Neurol Sci. 2006;248(1-2):151-7.http://dx.doi.org/10.1016/j.jns.2006.05.030
9. Zibetti M, Merola A, Rizzi L, Ricchi V, Angrisano S, Azzaro C et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Mov Disord. 2011;26(13):2327-34.http://dx.doi.org/10.1002/mds.23903
10. Chaudhuri KR, Healy D, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-45.http://dx.doi.org/10.1016/S1474-4422(06)70373-8
11. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord. 2010;25(15):2493-500.http://dx.doi.org/10.1002/mds.23394
12. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Nonrecognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2002;8(3):193-7.http://dx.doi.org/10.1016/S1353-8020(01)00015-3
13. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704-9.http://dx.doi.org/10.1002/mds.22868
14. O’Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Non motor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord. 2008;23(1):101-6.http://dx.doi.org/10.1002/mds.21813
15. Ansari KA, Johnson A. Olfactory function in patients with Parkinson’s disease. J Chronic Dis. 1975;28(9):493-7.http://dx.doi.org/10.1016/0021-9681(75)90058-2
16. Korten JJ, Meulstee J. Olfactory disturbances in Parkinsonism. Clin Neurol Neurosurg. 1980;82(2):113-8.http://dx.doi.org/10.1016/0303-8467(80)90005-0
17. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson’s disease. Neurology. 1983;33(7):943-6.http://dx.doi.org/10.1212/WNL.33.7.943
18. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1987;50(1):88-9.
19. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38(8):1237-44.
20. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1992;55(2):138-42.http://dx.doi.org/10.1136/jnnp.55.2.138
21. Saifee T, Lees AJ, Silveira-Moriyama L. Olfactory function in Parkinson’s disease in ON versus OFF states. J Neurol Neurosurg Psychiatry. 2010;81(11):1293-95.http://dx.doi.org/10.1136/jnnp.2009.182022
22. Bohnen NI, Muller ML, Kotagal V, et al. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain. 2010;133(6):1747-54.http://dx.doi.org/10.1093/brain/awq079
23. Hoyles K, Sharma JC. Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach. J Neurol. 2013;260(12):2951-8.http://dx.doi.org/10.1007/s00415-013-6848-8
24. Noyce AJ, Bestwock JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893-901.http://dx.doi.org/10.1002/ana.23687
25. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC. Olfactory function in essential tremor. Neurology. 1992;42(8):1631-2.
26. Kertelge L, Bruggemann N, Schmidt A, Tadic V. Wisse C, Dankert S et al. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson’s disease. Mov Disord. 2010;25(15):2665-9.http://dx.doi.org/10.1002/mds.23272
27. Alcalay RN, Siderowf A, Ottman R et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 2011;76(4):319-26.http://dx.doi.org/10.1212/WNL.0b013e31820882aa
28. Silveira-Moriyama L, Munhoz RP, Carvalho MJ, Raskin S, Rogaeva E, Aguiar PC et al. Olfactory heterogeneity in LRRK2 related Parkinsonism. Mov Disord. 2010;25:2879-83.http://dx.doi.org/10.1002/mds.23325
29. Marras C, Schule B, Munhoz RP, Rogaeva E, Langston JW, Kasten M et al. Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology. 2011;77(4):325-33.http://dx.doi.org/10.1212/WNL.0b013e318227042d
30. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K et al. Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol. 2008;63(2):167-73.http://dx.doi.org/10.1002/ana.21291
31. Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell. Ann Neurol. 2001;50(1):34-41.http://dx.doi.org/10.1002/ana.1049
32. Ponsen MM, Stoffers D, Booij J, Eck-Smit BL, Wolters ECH, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol. 2004;56(2):173-81.http://dx.doi.org/10.1002/ana.20160
33. Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson’s disease: a 3 year longitudinal study. Brain. 2012;135(1):161-9.http://dx.doi.org/10.1093/brain/awr321
34. Schenk CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25(2):120-38.
35. Postuma RB, Montplaisir J. Predicting Parkinson’s disease: why, when, and how? Parkinsonism Relat Disord. 2009;15 Suppl 3:S105-9.http://dx.doi.org/10.1016/S1353-8020(09)70793-X
36. American Academy of Sleep Medicine. ICSD - International classification of sleep disorders: diagnostic and coding manual. Westchester: American Sleep Disorders Association; 1990.
37. Postuma RB, Arnulf I, Hogl B, Iranzo A, Miyamoto T, Dauvilliers Y et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord 2012;27(7):913-6.http://dx.doi.org/10.1002/mds.25037
38. Postuma RB, Gagnon JF, Montplaisir J. Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 2013;14(8):763-7.http://dx.doi.org/10.1016/j.sleep.2012.09.001
39. De Cock VC, Vidailhet M, Leu S, Teixeira A, Apartis E, Elbaz A et al. Restoration of normal motor control in Parkinson’s disease during REM sleep. Brain. 2007;130(2):450-6.http://dx.doi.org/10.1093/brain/awl363
40. Munhoz RP, Teive HA, Eleftherohorinou H, Coin LJ, Lees AJ, Silveira-Moriyama L. Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2013;84(8):883-7.http://dx.doi.org/10.1136/jnnp-2012-304440
41. Vendette M, Gagnon JF, Décary A, Massicotte-Marquez J, Postuma RB, Doyon J et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology. 2007;69(19):1843-9.http://dx.doi.org/10.1212/01.wnl.0000278114.14096.74
42. Munhoz RP, Teive HA. REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism? Clin Neurol Neurosurg. 2014;127:71-4.http://dx.doi.org/10.1016/j.clineuro.2014.09.014
43. Starkstein SE, Brockman S, Hayhow BD. Psychiatric syndromes in Parkinson’s disease. Curr Opin Psychiatry. 2012;25(6):468-72.http://dx.doi.org/10.1097/YCO.0b013e3283577ed1
44. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord. 2003;18(4):414-8.http://dx.doi.org/10.1002/mds.10387
45. Rickards H. Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry. 2005;76 Suppl 1:i48-52.http://dx.doi.org/10.1136/jnnp.2004.060426
46. Ishihara L, Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord. 2006;21(8):1066-72.http://dx.doi.org/10.1002/mds.20980
47. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57(3):456-62.http://dx.doi.org/10.1212/WNL.57.3.456
48. Cersosimo MG, Benarroch EE. Autonomic involvement in Parkinson’s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci. 2012;313(1-2):57-63.http://dx.doi.org/10.1016/j.jns.2011.09.030
49. Cheshire Jr WP, Wszolek ZK. Body mass index is reduced early in Parkinson’s disease. Parkinsonism Relat Disord. 2005;11(1):35-8.http://dx.doi.org/10.1016/j.parkreldis.2004.07.001
50. Munhoz RP, Ribas CB. Body mass index in Parkinson’s disease. Parkinsonism Relat Disord. 2005;11(6):407.http://dx.doi.org/10.1016/j.parkreldis.2005.02.001
51. Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A. Weight loss in Parkinson’s disease. Ann Neurol. 2003;53(5):676-9.http://dx.doi.org/10.1002/ana.10577
52. Munhoz RP, Werneck LC, Teive HA. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics. Clin Neurol Neurosurg. 2010;112(5):431-5.http://dx.doi.org/10.1016/j.clineuro.2010.03.003
53. Aarsland D, Beyer MK, Kurz MW. Dementia in Parkinson’s disease. Curr Opin Neurol. 2008;21(6):676-82.http://dx.doi.org/10.1097/WCO.0b013e3283168df0
54. Levy G, Schupf N, Tang MX, Cote LJ, Louis ED, Mejia H et al. Combined effect of age and severity on the risk of dementia in Parkinson’s disease. Ann Neurol. 2002;51(6):722-9.http://dx.doi.org/10.1002/ana.10219
55. Buter TC, Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017-22.http://dx.doi.org/10.1212/01.wnl.0000306632.43729.24
56. Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol. 2008;7(7):605-14.http://dx.doi.org/10.1016/S1474-4422(08)70114-5
57. Munhoz RP, Espay AJ, Morgante F, Li JY, Teive HÁ, Dunn E et al. Long-duration Parkinson’s disease: role of lateralization of motor features. Parkinsonism Relat Disord. 2013;19(1):77-80.http://dx.doi.org/10.1016/j.parkreldis.2012.07.008
58. Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM. Dementia and visual hallucinations associated with limbic pathology in Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(3):196-204.http://dx.doi.org/10.1016/j.parkreldis.2008.05.007
59. Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D et al. Diagnostic criteria for psychosis in Parkinson’s disease: report of an NINDS, NIMH work group. Mov Disord. 2007;22(8):1061-8.http://dx.doi.org/10.1002/mds.21382
60. Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CF, Kurlan R et al. Longitudinal outcome of Parkinson’s disease patients with psychosis. Neurology. 2003;60(11):1756-61.http://dx.doi.org/10.1212/01.WNL.0000068010.82167.CF